Am J Citarinostat purchase Physiol 1998, 274:L1024-L1029.PubMed 28. Lum H, Jaffe HA, Schulz IT, Masood A, RayChaudhury A, Green RD: Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. Am J Physiol 1999, 277:C580-C588.PubMed 29. Waschke J, Drenckhahn D, Adamson RH, Barth H, Curry FE: cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. Am J Physiol Heart Circ Physiol 2004, 287:H2427-H2433.PubMedCrossRef 30. He P, Zeng M, Curry FE: Dominant role of cAMP in regulation of microvessel permeability. Am J Physiol Heart Circ Physiol 2000, 278:H1124-H1133.PubMed 31. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE: Microvascular permeability

and number of tight junctions are modulated by cAMP. Am J Physiol 1998, 274:H1885-H1894.PubMed www.selleckchem.com/products/emricasan-idn-6556-pf-03491390.html 32. Casnocha SA, Eskin SG, Hall ER, McIntire LV: Permeability of human endothelial monolayers: LY2090314 effect of vasoactive agonists and cAMP. J Appl Physiol 1989, 67:1997–2005.PubMed 33. Bogatcheva NV, Zemskova MA, Kovalenkov Y, Poirier C, Verin AD: Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial

cells (HLMVEC) hyperpermeability. J Cell Physiol 2009, 221:750–759.PubMedCrossRef 34. Chiu VC, Haynes DH: High and low affinity Ca2+ binding to the sarcoplasmic reticulum: use of a high-affinity fluorescent calcium indicator. Biophys J 1977, 18:3–22.PubMedCrossRef 35. Shaywitz AJ, Greenberg ME, CREB: A stimulus-induced transcription factor activated

by a diverse array of extracellular signals. Annu Rev Biochem 1999, 68:821–861.PubMedCrossRef 36. Grader-Beck T, van Puijenbroek AA, Nadler LM, Boussiotis VA: cAMP Dolichyl-phosphate-mannose-protein mannosyltransferase inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression. Blood 2003, 101:998–1006.PubMedCrossRef 37. Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM: Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol 2006, 176:7557–7565.PubMed 38. Tessier J, Green C, Padgett D, Zhao W, Schwartz L, Hughes M, et al.: Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis. Infect Immun 2007, 75:1895–1903.PubMedCrossRef 39. Walsh DA, Perkins JP, Krebs EG: An adenosine 3′,5′-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem 1968, 243:3763–3765.PubMed 40. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al.: Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396:474–477.PubMedCrossRef 41. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, et al.: A family of cAMP-binding proteins that directly activate Rap1. Science 1998, 282:2275–2279.PubMedCrossRef 42.